AAAAAA

   
Results: 1-10 |
Results: 10
The face validity of a final professional clinical examination
Authors: Tweed, M Cookson, J
Citation: M. Tweed et J. Cookson, The face validity of a final professional clinical examination, MED EDUC, 35(5), 2001, pp. 465-473
The effect of differing support surfaces on the efficacy of chest compressions using a resuscitation manikin model
Authors: Tweed, M Tweed, C Perkins, GD
Citation: M. Tweed et al., The effect of differing support surfaces on the efficacy of chest compressions using a resuscitation manikin model, RESUSCITAT, 51(2), 2001, pp. 179-183
Legal vulnerability of assessment tools
Authors: Tweed, M Miola, J
Citation: M. Tweed et J. Miola, Legal vulnerability of assessment tools, MED TEACH, 23(3), 2001, pp. 312-314
The design and synthesis of thrombin inhibitors: Analogues of MD805 containing non-polar surrogates for arginine at the P1 position
Authors: Baettig, U Brown, L Brundish, D Dell, C Furzer, A Garman, S Janus, D Kane, PD Smith, G Walker, CV Cockcroft, XL Ambler, J Mitchelson, A Talbot, MD Tweed, M Wills, N
Citation: U. Baettig et al., The design and synthesis of thrombin inhibitors: Analogues of MD805 containing non-polar surrogates for arginine at the P1 position, BIOORG MED, 10(14), 2000, pp. 1563-1566
The design and synthesis of thrombin inhibitors: The introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors
Authors: Hayler, J Kane, PD LeGrand, D Lugrin, F Menear, K Price, R Allen, M Cockcroft, XL Ambler, J Butler, K Dunnet, K Mitchelson, A Talbot, M Tweed, M Wills, N
Citation: J. Hayler et al., The design and synthesis of thrombin inhibitors: The introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors, BIOORG MED, 10(14), 2000, pp. 1567-1570
Enigma puzzle
Authors: Tweed, M
Citation: M. Tweed, Enigma puzzle, NEW SCI, 168(2265), 2000, pp. 65-65
Fossilised minds
Authors: Tweed, M
Citation: M. Tweed, Fossilised minds, NEW SCI, 165(2231), 2000, pp. 51-51
The discovery of orally available thrombin inhibitors: Optimisation of theP1 pharmacophore
Authors: Ambler, J Bentley, D Brown, L Dunnet, K Farr, D Janus, D Le Grand, D Menear, K Mercer, M Talbot, M Tweed, M Wathey, B
Citation: J. Ambler et al., The discovery of orally available thrombin inhibitors: Optimisation of theP1 pharmacophore, BIOORG MED, 9(8), 1999, pp. 1103-1108
Studies towards the identification of potent, selective and bioavailable thrombin inhibitors
Authors: Ambler, J Baker, E Bentley, D Brown, L Butler, K Butler, P Farr, D Dunnet, K Le Grand, D Hayler, J Janus, D Jones, D Menear, K Mercer, M Smith, G Talbot, M Tweed, M
Citation: J. Ambler et al., Studies towards the identification of potent, selective and bioavailable thrombin inhibitors, BIOORG MED, 9(5), 1999, pp. 737-742
The discovery of orally available thrombin inhibitors: Studies towards theoptimisation of CGH1668
Authors: Ambler, J Baker, E Brown, L Butler, P Farr, D Dunnet, K Le Grand, D Janus, D Jones, D Menear, K Mercer, M Smith, G Talbot, M Tweed, M
Citation: J. Ambler et al., The discovery of orally available thrombin inhibitors: Studies towards theoptimisation of CGH1668, BIOORG MED, 8(24), 1998, pp. 3583-3588
Risultati: 1-10 |